Intensive Cardiac Care Unit, Heart and Vessel Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Clin Cardiol. 2012 Apr;35(4):200-4. doi: 10.1002/clc.20975. Epub 2011 Dec 6.
The intraaortic balloon pump (IABP) is the most commonly used mechanical circulatory support for patients with acute coronary syndromes and cardiogenic shock. Nevertheless, IABP-related complications are still frequent and associated with a poor prognosis.
To prospectively assess the incidence and predictors of complications in patients treated with IABP.
A total of 481 patients treated with IABP were prospectively enrolled in our registry (the Florence Registry). At multivariable logistic regression analysis the following variables were independent predictors for complications (when adjusted for age >75 years, eGFR and time length of IABP support): use of inotropes (OR 2.450, P < 0.017), nadir platelet count (1000/µL step; OR 0.990, P < 0.001), admission lactate (OR 1.175, P = 0.003). Nadir platelet count showed a negative correlation with length of time of IABP implantation (r-0.31; P < 0.001). A nadir platelet count cutoff value of less than 120,000 was identified using a receiver operating characteristic (ROC) curve for the development of complications (area under the curve [AUC] 0.70; P < 0.001).
Complications were observed in the 13.1%, among whom 33 of 63 showed major bleeding. The incidence of complications was higher in patients aged >75 years (P = 0.015) and in those who had an IABP implanted for more than 24 hours (P = 0.001). Patients with complications showed an in Intensive Cardiac Care Unit (ICCU) mortality higher than patients who did not (44.4% vs 17.2%, P < 0.001).
In consecutive patients treated with IABP support, the degree of hemodynamic impairment and the decrease in platelet count were independent predictors of complications, whose development was associated with higher in-ICCU mortality.
主动脉内球囊反搏泵(IABP)是急性冠状动脉综合征和心源性休克患者最常用的机械循环支持。然而,IABP 相关并发症仍然很常见,并与预后不良有关。
前瞻性评估接受 IABP 治疗的患者并发症的发生率和预测因素。
我们的注册研究(佛罗伦萨注册研究)前瞻性纳入了 481 例接受 IABP 治疗的患者。在多变量逻辑回归分析中,以下变量是并发症的独立预测因素(当调整年龄>75 岁、eGFR 和 IABP 支持时间长度时):使用正性肌力药(OR 2.450,P < 0.017)、血小板计数最低值(1000/µL 步;OR 0.990,P < 0.001)、入院时乳酸(OR 1.175,P = 0.003)。血小板计数最低值与 IABP 植入时间呈负相关(r=-0.31;P < 0.001)。使用受试者工作特征(ROC)曲线确定血小板计数最低值<120,000 为发生并发症的截断值(曲线下面积[AUC]0.70;P < 0.001)。
并发症发生率为 13.1%,其中 63 例中有 33 例出现大出血。年龄>75 岁(P = 0.015)和 IABP 植入时间超过 24 小时(P = 0.001)的患者并发症发生率较高。并发症患者的 ICU 死亡率高于无并发症患者(44.4%比 17.2%,P < 0.001)。
在连续接受 IABP 支持治疗的患者中,血流动力学损害程度和血小板计数下降是并发症的独立预测因素,并发症的发生与 ICU 死亡率升高有关。